Literature DB >> 33495214

Integration of Continuous Renal Replacement Therapy in a Meropenem Population Pharmacokinetics Model in Critically Ill Children.

Agathe Béranger1, Naïm Bouazza2, Mehdi Oualha2,3.   

Abstract

Entities:  

Keywords:  pediatric drug therapy; population pharmacokinetics

Mesh：

Substances：

Year:  2021        PMID： 33495214      PMCID： PMC8097407          DOI： 10.1128/AAC.02542-20

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  5 in total

1.  Antimicrobial Disposition During Pediatric Continuous Renal Replacement Therapy Using an Ex Vivo Model.

Authors:  Prashant J Purohit; Mohammed H Elkomy; Adam Frymoyer; Scott M Sutherland; David R Drover; Gregory B Hammer; Felice Su
Journal:  Crit Care Med       Date:  2019-09       Impact factor: 7.598

2.  Population Pharmacokinetics and Pharmacodynamics of Meropenem in Critically Ill Pediatric Patients.

Authors:  Jumpei Saito; Kensuke Shoji; Yusuke Oho; Hiroki Kato; Shotaro Matsumoto; Satoshi Aoki; Hidefumi Nakamura; Takanori Ogawa; Mayumi Hasegawa; Akimasa Yamatani; Isao Miyairi
Journal:  Antimicrob Agents Chemother       Date:  2021-01-20       Impact factor: 5.191

3.  Population pharmacokinetics of meropenem in critically ill children with different renal functions.

Authors:  Mélanie Rapp; Saïk Urien; Frantz Foissac; Agathe Béranger; Naïm Bouazza; Sihem Benaboud; Emmanuelle Bille; Yi Zheng; Inès Gana; Florence Moulin; Fabrice Lesage; Sylvain Renolleau; Jean Marc Tréluyer; Déborah Hirt; Mehdi Oualha
Journal:  Eur J Clin Pharmacol       Date:  2019-10-26       Impact factor: 2.953

4.  Pharmacokinetics and Target Attainment of Antibiotics in Critically Ill Children: A Systematic Review of Current Literature.

Authors:  Stan J F Hartman; Roger J Brüggemann; Lynn Orriëns; Nada Dia; Michiel F Schreuder; Saskia N de Wildt
Journal:  Clin Pharmacokinet       Date:  2020-02       Impact factor: 6.447

5.  Ex Vivo Characterization of Effects of Renal Replacement Therapy Modalities and Settings on Pharmacokinetics of Meropenem and Vaborbactam.

Authors:  Fekade B Sime; Saurabh Pandey; Nermin Karamujic; Suzanne Parker; Elizabeth Alexander; Jeffery Loutit; Stephanie Durso; David Griffith; Jeffrey Lipman; Steven C Wallis; Jason A Roberts
Journal:  Antimicrob Agents Chemother       Date:  2018-09-24       Impact factor: 5.191
  5 in total
  1 in total

1.  Reply to Béranger et al., "Integration of Continuous Renal Replacement Therapy in a Meropenem Population Pharmacokinetics Model in Critically Ill Children".

Authors:  Jumpei Saito; Kensuke Shoji; Yusuke Oho; Hiroki Kato; Shotaro Matsumoto; Satoshi Aoki; Hidefumi Nakamura; Takanori Ogawa; Mayumi Hasegawa; Akimasa Yamatani; Isao Miyairi
Journal:  Antimicrob Agents Chemother       Date:  2021-03-18       Impact factor: 5.191
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.